Does tingling on the tip of the nose during a shingles (herpes zoster) outbreak indicate potential involvement of the eye or retina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tingling on the Nose in Shingles: Implications for Ocular Involvement

Tingling on the tip of the nose during a shingles outbreak is a significant warning sign for potential eye involvement and should prompt immediate ophthalmological evaluation to prevent vision-threatening complications.

Understanding the Connection Between Nasal Tingling and Ocular Shingles

  • Tingling on the tip of the nose during herpes zoster (shingles) is known as Hutchinson's sign, which indicates involvement of the nasociliary branch of the trigeminal nerve 1, 2
  • This sign strongly suggests that the virus may affect the eye because the same nerve branch supplies both the tip of the nose and parts of the eye 2
  • When herpes zoster affects the ophthalmic division of the trigeminal nerve, it's called Herpes Zoster Ophthalmicus (HZO) 2

Potential Ocular Complications

  • Herpes zoster affecting the eye can cause various complications including:

    • Conjunctivitis (inflammation of the conjunctiva) 1
    • Keratitis (inflammation of the cornea) 1
    • Epithelial keratitis that may be punctate or pseudodendritic 1
    • Uveitis (inflammation of the uvea) 1
    • Retinitis (inflammation of the retina) 1
    • Secondary glaucoma 3
    • Corneal scarring and late corneal anesthesia or dry eye 1
  • In recurrent disease (shingles), keratitis of the epithelium or stroma can lead to:

    • Subsequent scarring 1
    • Corneal anesthesia 1
    • Dry eye syndrome 1
    • Vision loss in severe cases 2

Clinical Course and Management

  • Varicella zoster virus (VZV) becomes latent in cerebral or posterior root ganglia after primary infection (chickenpox) and can reactivate decades later as shingles 3
  • The trigeminal ganglion is one of the most commonly involved ganglia in herpes zoster 3
  • Daily ophthalmological review is necessary during acute illness when eye involvement is suspected 2
  • Treatment should include:
    • Non-preserved ocular lubricants every 2 hours throughout the acute illness 2
    • Consideration of topical corticosteroid drops to reduce ocular surface damage 2
    • Broad-spectrum topical antibiotics if corneal fluorescein staining or ulceration is present 2
    • Systemic antiviral therapy (acyclovir, valacyclovir, or famciclovir), ideally started within 72 hours of rash onset 4, 5

Prevention and Risk Factors

  • The recombinant zoster vaccine (RZV) is recommended for:
    • Immunocompetent adults aged 50 years or older 2
    • Immunocompromised patients 19 years and older 2
    • Adults who previously received the older zoster vaccine live (ZVL) 2
  • Risk factors for developing shingles include:
    • Advanced age 3, 5
    • Immunosuppression (HIV infection, chemotherapy, malignancies, chronic corticosteroid use) 3, 5
    • Declining cellular immune response 3

Important Considerations

  • Ocular involvement in herpes zoster can lead to rare but serious complications and generally merits immediate referral to an ophthalmologist 4
  • Antiviral medications are most effective when started within 72 hours after the onset of the rash 4, 5
  • Even in the absence of pain (which can occur in some patients), the presence of a rash along with tingling on the nose should prompt evaluation for potential eye involvement 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Herpes Zoster Ophthalmicus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.